• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌保护的进展。

Advances in myocardial protection.

作者信息

Seifert P C

机构信息

Halifax Medical Center, Dayton Beach, Florida, USA.

出版信息

J Cardiovasc Nurs. 1998 Apr;12(3):29-38. doi: 10.1097/00005082-199804000-00005.

DOI:10.1097/00005082-199804000-00005
PMID:9547450
Abstract

The success of cardiac surgery is due in large part to the myocardial protection techniques employed to maintain cardiac viability during the period of induced ischemic arrest. As the number of older, high-risk cardiac surgical patients increases, advances in myocardial protection have become necessary to achieve a quiet, bloodless operative field without the production of irreversible intraoperative myocardial damage. Current efforts to provide optimal myocardial protection have focused on the effects of cardioplegic perfusate temperature, distribution of cardioplegia flow, and components of the arresting solution. Minimally invasive techniques have expanded surgical options and have led to the development of new methods to protect the myocardium.

摘要

心脏手术的成功在很大程度上归功于在诱导性缺血停搏期间用于维持心脏活力的心肌保护技术。随着老年高危心脏手术患者数量的增加,心肌保护方面的进展对于实现安静、无血的手术视野且不产生不可逆的术中心肌损伤变得至关重要。目前为提供最佳心肌保护所做的努力集中在心脏停搏灌注液温度的影响、心脏停搏液流动的分布以及停搏液的成分上。微创技术扩大了手术选择,并导致了保护心肌的新方法的发展。

相似文献

1
Advances in myocardial protection.心肌保护的进展。
J Cardiovasc Nurs. 1998 Apr;12(3):29-38. doi: 10.1097/00005082-199804000-00005.
2
Continuous warm blood cardioplegia: a new technique for myocardial protection.持续温血心脏停搏液灌注:一种心肌保护的新技术。
J Extra Corpor Technol. 1990 Fall;22(3):107-9.
3
Postcardioplegia acute cardiac dysfunction and reperfusion injury.心脏停搏后急性心脏功能障碍与再灌注损伤。
J Cardiothorac Vasc Anesth. 1993 Aug;7(4 Suppl 2):6-18. doi: 10.1016/1053-0770(93)90092-y.
4
Cardioplegia-induced damage to ischemic immature myocardium is independent of oxygen availability.心脏停搏液诱导的缺血未成熟心肌损伤与氧供无关。
Ann Thorac Surg. 1990 Dec;50(6):934-9. doi: 10.1016/0003-4975(90)91125-u.
5
Adverse effects of crystalloid cardioplegia and slow cooling for protection of immature rat hearts.晶体心脏停搏液和缓慢降温对未成熟大鼠心脏保护的不良反应。
Ann Thorac Surg. 1996 Sep;62(3):702-9. doi: 10.1016/s0003-4975(96)00354-2.
6
Rapid cooling contracture of the myocardium. The adverse effect of prearrest cardiac hypothermia.心肌快速冷却挛缩。心脏骤停前低温的不良影响。
J Thorac Cardiovasc Surg. 1990 Aug;100(2):240-9.
7
Is blood versus crystalloid cardioplegia relevant? Significantly improved protection may require new cardioplegic concepts!血液与晶体停搏液相比重要吗?显著改善的心肌保护可能需要新的心脏停搏概念!
Interact Cardiovasc Thorac Surg. 2008 Dec;7(6):1162-3. doi: 10.1510/icvts.2008.186494. Epub 2008 Sep 10.
8
Enflurane and isoflurane, but not halothane, protect against myocardial reperfusion injury after cardioplegic arrest with HTK solution in the isolated rat heart.在离体大鼠心脏中,恩氟烷和异氟烷(而非氟烷)可在使用HTK液心脏停搏后预防心肌再灌注损伤。
Anesth Analg. 1998 Dec;87(6):1221-7. doi: 10.1097/00000539-199812000-00001.
9
[Myocardial protection: which method of cardioplegia is better?].[心肌保护:哪种心脏停搏方法更好?]
Medicina (Kaunas). 2002;38(8):797-800.
10
Age-related changes in the ability of hypothermia and cardioplegia to protect ischemic rabbit myocardium.低温和心脏停搏保护缺血兔心肌能力的年龄相关变化。
J Thorac Cardiovasc Surg. 1988 Nov;96(5):717-24.